- JP-listed companies
- Income statement
(4881) Income statement
Market cap
¥2.9B
P/E ratio
Funpep develops new medicines using functional peptides and its STEP UP drug discovery platform, focusing on treatments like SR-0379 for skin ulcers.
| 2015/12 | 2016/12 | 2017/12 | 2018/12 | 2019/12 | 2020/12 | 2021/12 | 2022/12 | 2023/12 | 2024/12 | 2025/12 | |
| Revenue | 175 | 464 | 101 | 356 | 301 | 3 | 127 | 1 | 1 | 6 | 0 |
| Revenue growth (%) | - | ||||||||||
| Operating margin (%) | - | - | - | ||||||||
| Operating income | - | - | - | -14 | -286 | -565 | -745 | -1,169 | -994 | -902 | -1,649 |
| Income before tax | 22 | 152 | -194 | -9 | -232 | -505 | -680 | -1,175 | -940 | -896 | -1,634 |
| Pretax margin (%) | 12.6 | 32.7 | -191.4 | -2.5 | -77.1 | -17,006.1 | -535.7 | -110,143.3 | -177,437.7 | -14,625.9 | -520,245.9 |
| Provision for income taxes | - | - | - | 3 | 3 | - | - | -3 | -7 | -7 | -100 |
| Effective tax rate (%) | - | - | - | - | - | ||||||
| Net income | 11 | 102 | -204 | -12 | -235 | -508 | -682 | -1,173 | -933 | -889 | -1,912 |
| Earnings per share | 7,276.57 | 46,071.23 | -18.26 | -1.06 | -20.25 | -40.37 | -39.58 | -61.04 | -39.63 | -31.98 | -50.2 |
| Dividend per share | - | - | - | - | - | - | - | - | - | - | - |